[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$qures Graphic](https://lunarcrush.com/gi/w:26/t:$qures.png) $qures

$qures sees a surge in social media activity with high engagement on gene therapy discussions. Analysts are optimistic about $qures's pipeline, but competition remains a factor.

### About $qures
Analysis of social media activity related to the stock ticker $qures, likely representing uniQure N.V.  

### Insights [#](/topic/$qures/insights)
- $qures Creators hit a 52-Week high of X for the day
- $qures Creators hit an all time of X for the day
- $qures Mentions hit a 52-Week high of X for the day
- $qures Mentions hit an all time of X for the day

### Engagements: XX [#](/topic/$qures/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$qures/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$qures/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXX +712%  
**1-Year High**: XXXXX on 2025-06-30  
**1-Year Low**: X on 2025-07-08  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$qures/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$qures/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$qures/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-10-16  
**1-Year Low**: X on 2025-04-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$qures/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$qures/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$qures/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $qures in the last XX hours which is down XX% from X in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-10-16  
**1-Year Low**: X on 2025-04-27  

**Top assets mentioned**
In the posts about $qures in the last XX hours

[uniQure N.V. (QURE)](/topic/$qure)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)

**Top topics mentioned**
In the posts about $qures in the last XX hours

[$clpt](/topic/$clpt), [$regns](/topic/$regns), [$qure](/topic/$qure), [approved](/topic/approved), [$rhhbys](/topic/$rhhbys), [$ptcts](/topic/$ptcts), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [stocks healthcare](/topic/stocks-healthcare), [$regn](/topic/$regn), [$rhhby](/topic/$rhhby), [stocks](/topic/stocks), [youtube](/topic/youtube)

### Top Social Posts [#](/topic/$qures/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"The sympathy play: $CLPT (ClearPoint Neuro) provides the brain delivery tech that $QUREs gene therapy requires. They move together. Watch $CLPT as your canaryif it fails $QURE could follow"  
[X Link](https://x.com/_samputnam/status/1978868026238816277) [@_samputnam](/creator/x/_samputnam) 2025-10-16T16:57Z XXX followers, XXX engagements


"$CLPT fanatics have been screaming about this for years now. The lowest risk gene cell therapy programs you can make are for the CNS"  
[X Link](https://x.com/AB1001_disciple/status/1977777641811014077) [@AB1001_disciple](/creator/x/AB1001_disciple) 2025-10-13T16:45Z XXX followers, 3559 engagements


"It looks like AAV gene therapy is finding its niche: local delivery of relatively low doses (E10-E12 total vg) in tissues as contained as possible. Recent clinical wins by $QURE's AMT-130 (intra-parenchymal Huntington's) and $REGN's DB-OTO (intracochlear inherited deafness) support this trend. These follow prior approved drugs like $RHHBY's Luxturna (subretinal LCA2) and $PTCT's Upstaza (intra-parenchymal AADC deficiency) also delivered locally. $NVS' Zolgensma is a special case -- although delivered systemically at relatively high doses the infant BBB remains permissive allowing efficient"  
[X Link](https://x.com/GerardCaelles/status/1977771288660791721) [@GerardCaelles](/creator/x/GerardCaelles) 2025-10-13T16:19Z 1099 followers, 13.8K engagements


"@ReplyGuy_Cap They are big in Alzheimers and HD and $qures pipeline could be a perfect fit"  
[X Link](https://x.com/canoebrookbl/status/1977391259338547386) [@canoebrookbl](/creator/x/canoebrookbl) 2025-10-12T15:09Z XXX followers, XXX engagements